{"entity":{"type":"insider","cik":"0001888829","url":"/insider/0001888829","json_url":"/insider/0001888829.json","name":"Samsara BioCapital GP, LLC","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":11,"n_filings":8,"first":"2023-10-18","last":"2026-05-22","span_basis":"filed_date"},"name_variants":[{"name":"Samsara BioCapital GP, LLC","source":"filing","n_filings":8,"first_seen":"2023-10-18","last_seen":"2026-05-22"}],"transactions":[{"id":5752533,"accession":"0001231919-26-000532","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001231919-26-000532","line_url":"/filing/0001231919-26-000532#line-4","is_derivative":false,"issuer_cik":"0001253170","issuer_name":"Kalaris Therapeutics, Inc.","issuer_ticker":"KLRS","issuer_name_source":null,"issuer_url":"/issuer/0001253170","owner_cik":null,"owner_name":"Samsara BioCapital, L.P.; Samsara BioCapital GP, LLC; Samsara Opportunity Fund GP, LLC; Samsara Opportunity Fund, L.P.","owner_display_name":"Samsara BioCapital, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":244300.0,"shares_display":"244,300","price_per_share":4.83,"price_display":"4.83","price_state":"stated","total_value":1179969.0,"total_display":"1,179,969.00","total_whole":"1,179,969","shares_owned_after":2224147.0,"shares_owned_after_display":"2,224,147","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-05-20","filed_date":"2026-05-22","scope":"insider"},{"id":5799467,"accession":"0001231919-26-000166","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001231919-26-000166","line_url":"/filing/0001231919-26-000166#line-1","is_derivative":false,"issuer_cik":"0001253170","issuer_name":"Kalaris Therapeutics, Inc.","issuer_ticker":"KLRS","issuer_name_source":null,"issuer_url":"/issuer/0001253170","owner_cik":null,"owner_name":"Samsara Opportunity Fund GP, LLC; Samsara BioCapital, L.P.; Samsara Opportunity Fund, L.P.; Samsara BioCapital GP, LLC","owner_display_name":"Samsara Opportunity Fund GP, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":479847.0,"shares_display":"479,847","price_per_share":10.42,"price_display":"10.42","price_state":"stated","total_value":5000005.74,"total_display":"5,000,005.74","total_whole":"5,000,006","shares_owned_after":1979847.0,"shares_owned_after_display":"1,979,847","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-12-18","filed_date":"2026-02-17","scope":"insider"},{"id":5153744,"accession":"0001415889-25-008275","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-008275","line_url":"/filing/0001415889-25-008275#line-1","is_derivative":false,"issuer_cik":"0001699737","issuer_name":"Mineralys Therapeutics, Inc.","issuer_ticker":"MLYS","issuer_name_source":null,"issuer_url":"/issuer/0001699737","owner_cik":null,"owner_name":"Samsara BioCapital, L.P.","owner_display_name":"Samsara BioCapital, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":600000.0,"shares_display":"600,000","price_per_share":13.5,"price_display":"13.50","price_state":"stated","total_value":8100000.0,"total_display":"8,100,000.00","total_whole":"8,100,000","shares_owned_after":5674916.0,"shares_owned_after_display":"5,674,916","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-13","filed_date":"2025-03-17","scope":"insider"},{"id":2449711,"accession":"0001415889-24-027861","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001415889-24-027861","line_url":"/filing/0001415889-24-027861","is_derivative":false,"issuer_cik":"0001253170","issuer_name":"Neurogene Inc.","issuer_ticker":"NGNE","issuer_name_source":null,"issuer_url":"/issuer/0001253170","owner_cik":null,"owner_name":"Samsara BioCapital, L.P.; AKKARAJU SRINIVAS","owner_display_name":"Samsara BioCapital, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":48770.0,"shares_display":"48,770","price_per_share":25.827815870412138,"price_display":"25.83","price_state":"stated","total_value":1259622.58,"total_display":"1,259,622.58","total_whole":"1,259,623","shares_owned_after":1689105.0,"shares_owned_after_display":"1,689,105","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-11-26","filed_date":"2024-11-27","scope":"insider","n_lines":4},{"id":2330007,"accession":"0001415889-24-015250","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-015250","line_url":"/filing/0001415889-24-015250#line-1","is_derivative":false,"issuer_cik":"0001253170","issuer_name":"CARGO Therapeutics, Inc.","issuer_ticker":"CRGX","issuer_name_source":null,"issuer_url":"/issuer/0001253170","owner_cik":null,"owner_name":"Samsara BioCapital, L.P.; AKKARAJU SRINIVAS","owner_display_name":"Samsara BioCapital, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":294000.0,"shares_display":"294,000","price_per_share":17.0,"price_display":"17.00","price_state":"stated","total_value":4998000.0,"total_display":"4,998,000.00","total_whole":"4,998,000","shares_owned_after":4415689.0,"shares_owned_after_display":"4,415,689","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-05-30","filed_date":"2024-06-03","scope":"insider"},{"id":3251846,"accession":"0001415889-24-003859","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-003859","line_url":"/filing/0001415889-24-003859#line-1","is_derivative":false,"issuer_cik":"0001699737","issuer_name":"Mineralys Therapeutics, Inc.","issuer_ticker":"MLYS","issuer_name_source":null,"issuer_url":"/issuer/0001699737","owner_cik":null,"owner_name":"Samsara BioCapital, L.P.","owner_display_name":"Samsara BioCapital, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":555555.0,"shares_display":"555,555","price_per_share":13.5,"price_display":"13.50","price_state":"stated","total_value":7499992.5,"total_display":"7,499,992.50","total_whole":"7,499,993","shares_owned_after":5074916.0,"shares_owned_after_display":"5,074,916","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-02-12","filed_date":"2024-02-14","scope":"insider"},{"id":8255533,"accession":"0001209191-23-055621","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-055621","line_url":"/filing/0001209191-23-055621#line-2","is_derivative":false,"issuer_cik":"0001253170","issuer_name":"CARGO Therapeutics, Inc.","issuer_ticker":"CRGX","issuer_name_source":null,"issuer_url":"/issuer/0001253170","owner_cik":null,"owner_name":"AKKARAJU SRINIVAS; Samsara BioCapital, L.P.; Samsara BioCapital GP, LLC","owner_display_name":"AKKARAJU SRINIVAS","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":666666.0,"shares_display":"666,666","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":9999990.0,"total_display":"9,999,990.00","total_whole":"9,999,990","shares_owned_after":4121689.0,"shares_owned_after_display":"4,121,689","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-11-14","filed_date":"2023-11-16","scope":"insider"},{"id":7871922,"accession":"0001209191-23-053111","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-053111","line_url":"/filing/0001209191-23-053111#line-1","is_derivative":false,"issuer_cik":"0001699737","issuer_name":"Scholar Rock Holding Corp","issuer_ticker":"SRRK","issuer_name_source":null,"issuer_url":"/issuer/0001699737","owner_cik":null,"owner_name":"Samsara BioCapital, L.P.; Samsara BioCapital GP, LLC","owner_display_name":"Samsara BioCapital, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2189781.0,"shares_display":"2,189,781","price_per_share":6.85,"price_display":"6.85","price_state":"stated","total_value":14999999.85,"total_display":"14,999,999.85","total_whole":"15,000,000","shares_owned_after":6788609.0,"shares_owned_after_display":"6,788,609","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-10-16","filed_date":"2023-10-18","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001754068","name":"Kalaris Therapeutics, Inc.","url":"/issuer/0001754068","role":"Ten percent owner","n_filings":2,"first_seen":"2026-02-17","last_seen":"2026-05-22"},{"type":"issuer","type_label":"ISSUER","cik":"0001933414","name":"Mineralys Therapeutics, Inc.","url":"/issuer/0001933414","role":"Ten percent owner","n_filings":2,"first_seen":"2024-02-14","last_seen":"2025-03-17"},{"type":"issuer","type_label":"ISSUER","cik":"0001404644","name":"Neurogene Inc.","url":"/issuer/0001404644","role":"Ten percent owner","n_filings":1,"first_seen":"2024-11-27","last_seen":"2024-11-27"},{"type":"issuer","type_label":"ISSUER","cik":"0001966494","name":"CARGO Therapeutics, Inc.","url":"/issuer/0001966494","role":"Ten percent owner","n_filings":2,"first_seen":"2023-11-16","last_seen":"2024-06-03"},{"type":"issuer","type_label":"ISSUER","cik":"0001727196","name":"Scholar Rock Holding Corp","url":"/issuer/0001727196","role":"Ten percent owner","n_filings":1,"first_seen":"2023-10-18","last_seen":"2023-10-18"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001888829","retrieved_at":"2026-08-27T09:41:06+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}